TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma
ConclusionTNFSF9 is a tumor suppressor in HCC. Based on its immune stimulatory aspect and the tumor inhibition property, TNFSF9 may be a promising therapeutic target for HCC. Copyright © 2017 John Wiley & Sons, Ltd.
Source: Journal of Digestive Diseases - Category: Gastroenterology Authors: Yuling Shen, Yu Gan, Haifeng Gao, Yingchao Fan, Qing Wang, Hui Yuan, Yanfang Song, Jiadong Wang, Hong Tu Tags: Original article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Hepatocellular Carcinoma | Immunotherapy | Liver Cancer | Study | Transplants